A NEW RESEARCH STUDY IS available IN YOUR AREA

Do you have knee pain due to osteoarthritis?

Learn about a no-cost, new investigational drug to potentially treat symptoms of knee osteoarthritis.

A NEW RESEARCH STUDY IS available IN YOUR AREA

Do you have knee pain due to osteoarthritis?

Learn about a no-cost, new investigational drug to potentially treat symptoms of knee osteoarthritis.

Do you struggle with knee osteoarthritis?

Knee Osteoarthritis (OA) is a common joint disorder affecting about 12.4 million people in the U.S. The disorder causes pain around the knee joint, swelling, locking, and giving way of the knee. These disabilities usually develop over time, leading to difficulty walking, climbing stairs, and performing household chores, which can lower the quality of life.

If you’re struggling with knee OA, you may qualify for a new research study, now offered at select United States centers. The study is testing an investigational treatment for knee osteoarthritis expected to improve knee pain, function, and quality of life.

The investigational medication may help regenerate damaged cartilage and involves a single injection of stem cells directly into the knee joint. If you are eligible and participate, you will receive free study-related care, such as physical exams, laboratory tests, ECGs, knee X-rays, and MRI scans, at no cost.

FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA

  • 18 years of age or older
  • Have persisting knee pain for at least 3 months

About the study

The prevalence of osteoarthritis of the knee is present in 33.6% of Americans aged 65 and older. This rate is expected to increase with the aging of the population and the obesity epidemic. Cell-based therapy aiming at joint repair has been used to reduce knee osteoarthritis symptoms and the need for more invasive surgical treatments where non-operative alternatives have failed.

In this clinical trial, a new investigational treatment using stem cells is evaluated for its potential to improve knee pain, function, and quality of life by regenerating damaged cartilage in patients with knee osteoarthritis. The clinical trial will take approximately twelve months to complete and includes a single injection of stem cells directly into the knee joint. The clinical trial involves trial-related medical examinations, including physical exams, laboratory tests, ECGs, knee X-rays and MRI scans, and assessments made by medical investigators.

There will be no cost associated with participation in the trial. You may receive compensation for transportation and the time required to participate in the trial.

Why Participate?

If you’re struggling with knee osteoarthritis, you may qualify for a new research study, now being offered at select centers throughout the U.S. The study will assess the effects of an investigational treatment designed to regenerate damaged cartilage and relieve knee pain associated with osteoarthritis. It involves a single injection of stem cells into the affected knee joint. The effect of the treatment will be checked by medical assessments, checking for side effects, and completing questionnaires. If you qualify, you will receive:

N

No-cost Study Care

You will receive study-related care from experienced doctors, nurses, and research staff.

N

Exams

The study will include physical exams, laboratory tests, ECGs, knee X-rays and MRI scans, and other examination visits with a trained investigator.
N

Compensation

You might be eligible to receive compensation for your time and travel.

A NEW RESEARCH STUDY IS AVAILABLE IN YOUR AREA

Chat With A Research Coordinator

Fill out the form below, and you will be advised if you are eligible or not. If you meet the initial pre-screening criteria, you will be contacted by a study coordinator from a research location near you. If you do not meet the minimum criteria, we recommend submitting the form. Study criteria can change, and you could become eligible at a later date.

Fill out the form below to find out if you are eligible

© 2023 Accelerate Recruitment | Privacy Policy | Legal Notice